Steve Usdin's profile photo

Steve Usdin

Washington, D.C.

Washington Editor at BioCentury

Washington Editor, BioCentury. Author: Bureau of Spies & Engineering Communism.

Articles

  • 1 week ago | biocentury.com | Steve Usdin

    ARTICLE | Politics, Policy & LawTrade associations and biopharma CEOs are mobilizing to oppose the drug pricing policy By Steve Usdin, Washington Editor Pharmaceutical industry executives and lobbyists are in “Defcon 1,” the highest state of alarm, over President Donald Trump’s push to include a “most favored nation” policy for Medicaid drug purchases in budget reconciliation legislation.

  • 1 week ago | zephyrnet.com | Steve Usdin

    ARTICLE | Politics, Policy & LawBy Steve Usdin, Washington EditorBiopharma CEOs and lobbyists are confident that the budget reconciliation bill will include relief from the Inflation Reduction Act's so-called "pill penalty," but are scrambling to fend off White House efforts to insert "most favored nation" drug pricing provisions. Even if MFN is excluded from the reconciliation bill, the push to ensure that some U.S. drug prices fall below those in other industrialized nations isn't going away.

  • 1 week ago | biocentury.com | Steve Usdin

    ARTICLE | Politics, Policy & LawGOP appears willing to fix the ‘pill penalty,’ Trump is pushing for Medicaid most favored nation also By Steve Usdin, Washington Editor Biopharma CEOs and lobbyists are confident that the budget reconciliation bill will include relief from the Inflation Reduction Act’s so-called “pill penalty,” but are scrambling to fend off White House efforts to insert “most favored nation” drug pricing provisions.

  • 2 weeks ago | biocentury.com | Steve Usdin

    ARTICLE | Politics, Policy & LawBIO campaign adds industry voice to pro-vaccine chorusPublic health groups, industry trying to counter flood of anti-vaccine messaging — including from Trump administration officials By Steve Usdin, Washington Editor May 1, 2025 11:03 PM UTC“What’s more important? Is it the flag you raise or the hands you hold?

  • 2 weeks ago | biocentury.com | Steve Usdin

    ARTICLE | Politics, Policy & LawNew HHS vaccine policy could make it impossible to launch improved versions of vaccines By Steve Usdin, Washington Editor HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary are translating anti-vaccine rhetoric into action, announcing policies that could make it impossible to update or launch improved versions of marketed vaccines. Kennedy is justifying the policies with lies and misstatements that target vulnerable communities....

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
3K
Tweets
4K
DMs Open
No
steve usdin
steve usdin @steveusdin1
3 May 25

RT @BioCentury: Biopharma industry confident of IRA fix, hoping to dodge MFN, writes BioCentury's @SteveUsdin1 https://t.co/apTM0VaquL

steve usdin
steve usdin @steveusdin1
1 May 25

RT @BioCentury: Three big disconnects: BioCentury's sentiment survey showed that biotech is still in shock. But behind the data, three deep…

steve usdin
steve usdin @steveusdin1
29 Apr 25

FDA misses PDUFA goal for Stealth’s Barth syndrome treatment It isn’t clear whether staffing cuts or loss of FDA champions have caused FDA to miss the PDUFA goal for an ultrarare disease therapy. https://t.co/FnmhghTrgn